Cellbxhealth (LON:CLBX) Announces Quarterly Earnings Results

Cellbxhealth (LON:CLBX) issued its quarterly earnings results on Wednesday. The company reported GBX (0.24) EPS for the quarter, Digital Look Earnings reports.

Cellbxhealth Trading Down 4.9%

Cellbxhealth stock traded down GBX 0.07 during midday trading on Wednesday, reaching GBX 1.33. The stock had a trading volume of 900,639 shares, compared to its average volume of 4,237,635. Cellbxhealth has a twelve month low of GBX 0.85 and a twelve month high of GBX 2.70. The stock has a market capitalization of £15.13 million and a P/E ratio of -0.24.

About Cellbxhealth

CelLBxHealth plc is a precision CTC intelligence company specialising in innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology. Its patent-protected Parsortix® platform harvests CTCs from blood and can be integrated with existing laboratory instruments for comprehensive downstream analysis – including whole-cell imaging, proteomic profiling and full genomic workflows.
Commercial activities centre on (1) Product Sales: Accelerating Parsortix platform adoption and consumable sales through CROs and clinical lab partnerships.